Picture of Cyfuse Biomedical KK logo

4892 — Cyfuse Biomedical KK News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Table: Cyfuse Biomedical - Q1 parent results

May 15 (Reuters)- 
             Cyfuse Biomedical K.K. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2026        Mar 31, 2025       Dec 31, 2026  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            28 mln              24 mln            278 mln     
                 (+17.6 pct)        (+125.3 pct)       (+20.4 pct)   
  Operating     loss 215 mln        loss 240 mln        loss 1.08    
  Recurring     loss 223 mln        loss 162 mln        loss 1.06    
  Net           loss 224 mln        loss 162 mln        loss 1.06    
  EPS          loss 22.56 yen      loss 19.90 yen    loss 110.22 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Cyfuse Biomedical K.K.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T

Recent news on Cyfuse Biomedical KK

See all news